Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-I in post-menopausal breast cancer patients
- 1 January 1995
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 42 (1) , 23-30
- https://doi.org/10.1111/j.1365-2265.1995.tb02594.x
Abstract
OBJECTIVE Oestrogens, androgens and anti‐endocrine drugs such as tamoxifen and aminoglutethimide influence plasma Insulin‐like growth factor‐I (IGF‐I). IGF‐I, in turn, has been found to stimulate the peripheral aromatase in vitro. The aim of this study was to examine relations between sex hormones, IGF‐I and insulin‐like growth factor binding protein‐1 (IGFBP‐1) In post‐menopausal women with breast cancer. DESIGN To measure plasma sex steroids, sex hormone binding globulin (SHBG), IGF‐I, IGFBP‐1, Insulin and urinary oestrogen metabolites In post‐menopausal women with breast cancer not receiving any endocrine therapy. PATIENTS Thirty‐two patients had fasting blood samples obtained between 0800 and 1000h. A sub‐group of 10 patients had 24‐hour urine oestrogen metabolites determined. MEASUREMENTS Plasma steroids and proteins were measured by radioImmunoassays. Urinary oestrogens were measured by GC‐MS. RESULTS SHBG correlated negatively with plasma androstenedione (P < 0·001), insulin (P < 0·001), IGF‐I, height and plasma oestrone sulphate (P < 0·025 for all), but positively with plasma IGFBP‐1 (P < 0·025). IGFBP‐1 correlated negatively with IGF‐I (P < 0·001) and the testosterone/SHBG ratio (P < 0·05). Neither IGF‐I nor IGFBP‐1 correlated with any of the plasma or urinary sex hormones or with the oestrone/androstenedione and oestradiol/testosterone ratios. Multivariate analysis revealed plasma SHBG to correlate positively with IGFBP‐1 (P= 0·029) and negatively with Insulin (P= 0·031). Plasma IGFBP‐1 correlated negatively with IGF‐I (P < 0·0001) but not with insulin. CONCLUSION Our results do not suggest any influence of plasma sex steroids in physiological concentrations on IGF‐I or IGFBP‐1 in post‐menopausal breast cancer patients, nor do they indicate IGF‐I at physiological concentrations Influences the ratios between plasma oestrogens and their androgen precursors.Keywords
This publication has 44 references indexed in Scilit:
- Aging is associated with decreased suppression of insulin-like growth factor binding protein-1 by insulinJournal of Clinical Endocrinology & Metabolism, 1993
- Estrogen and Insulin Modulation of Intracellular Insulin-like Growth Factor Binding Proteins in Human Breast Cancer Cells: Possible Involvement in Lysosomal Hydrolases OversecretionBiochemical and Biophysical Research Communications, 1993
- Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patientsThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Inter‐relations between growth hormone, insulin, insulin‐like growth factor‐l (IGF‐I), IGF‐binding protein‐1 (IGFBP‐1) and sex hormone‐binding globulin in acromegalyClinical Endocrinology, 1991
- Effect of Tamoxifen on Serum Insulinlike Growth Factor I Levels in Stage I Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1990
- Postmenopausal estrogen synthesis and metabolism: Alterations caused by aromatase inhibitors used for the treatment of breast cancerJournal of Steroid Biochemistry, 1990
- Effects of aminoglutethimide on plasma estrone sulfate not caused by aromatase inhibitionJournal of Steroid Biochemistry, 1989
- Alterations in the urine excretion of estrogen metabolites in breast cancer women treated with aminoglutethimideThe Journal of Steroid Biochemistry and Molecular Biology, 1989
- The multicomponent analysis of estrogens in urine by ion exchange chromatography and GC-MS—I. Quantitation of estrogens after initial hydrolysis of conjugatesThe Journal of Steroid Biochemistry and Molecular Biology, 1987
- Increased 2-Hydroxylation of Estradiol as a Possible Mechanism for the Anti-Estrogenic Effect of Cigarette SmokingNew England Journal of Medicine, 1986